🔗 Share this article Individuals Stopping Slimming Jabs Put On Pounds Far More Rapidly Compared to People Using Diet and Exercise Weight management involves long-term strategies. New research suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle plans. Published data in a major health publication points out that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation. "Users using such drugs need to be cognizant of the risk of fast rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb. This pace of regain suggests a return to original mass in about 18 months. Comparing Treatments The analysis, which examined 37 of studies involving over 9,000 of patients, compared the outcomes of these new drugs with conventional dieting. Researchers note that people who lose weight through lifestyle changes alone typically experience a more gradual creep back—perhaps 0.1 kg a month—after stopping. Understanding the Rapid Regain Doctors propose the way of the injections is key to understanding the amplified rebound. The injections copy a body's own chemical called glucagon-like peptide-1, which controls appetite. "Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this medication results in appetite is uncontrolled, making overeating a significant risk." A Lifelong Issue? Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications. Many experts contend that, due to the high risk of relapse, the therapy might need to be life-long. This perspective is echoed by drug manufacturers, who state that the results "underscore the chronic character of excess weight," comparing it to managing diseases like hypertension. User Testimonies People who have discontinued the medication report a powerful resurgence of cravings. "I experienced something activating and I was suddenly ravenous," described an individual. The struggle is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy. Significant Adoption Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Use is more common among females compared to men. The middle-aged age group shows the highest usage rates. A large proportion obtain the drugs through private healthcare rather than public health services. Ultimately, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated behavioural management.
Weight management involves long-term strategies. New research suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle plans. Published data in a major health publication points out that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation. "Users using such drugs need to be cognizant of the risk of fast rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb. This pace of regain suggests a return to original mass in about 18 months. Comparing Treatments The analysis, which examined 37 of studies involving over 9,000 of patients, compared the outcomes of these new drugs with conventional dieting. Researchers note that people who lose weight through lifestyle changes alone typically experience a more gradual creep back—perhaps 0.1 kg a month—after stopping. Understanding the Rapid Regain Doctors propose the way of the injections is key to understanding the amplified rebound. The injections copy a body's own chemical called glucagon-like peptide-1, which controls appetite. "Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist. "Discontinuation of this medication results in appetite is uncontrolled, making overeating a significant risk." A Lifelong Issue? Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications. Many experts contend that, due to the high risk of relapse, the therapy might need to be life-long. This perspective is echoed by drug manufacturers, who state that the results "underscore the chronic character of excess weight," comparing it to managing diseases like hypertension. User Testimonies People who have discontinued the medication report a powerful resurgence of cravings. "I experienced something activating and I was suddenly ravenous," described an individual. The struggle is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy. Significant Adoption Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Use is more common among females compared to men. The middle-aged age group shows the highest usage rates. A large proportion obtain the drugs through private healthcare rather than public health services. Ultimately, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated behavioural management.